Earnings Per Share, Diluted in USD/shares of CorMedix Inc. from Q2 2013 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
CorMedix Inc. quarterly/annual Earnings Per Share, Diluted history and change rate from Q2 2013 to Q3 2025.
- CorMedix Inc. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was 1.26 USD/shares.
- CorMedix Inc. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2025 was 2 USD/shares.
- CorMedix Inc. annual Earnings Per Share, Diluted for 2024 was -0.3 USD/shares, a 67% increase from 2023.
- CorMedix Inc. annual Earnings Per Share, Diluted for 2023 was -0.91 USD/shares, a 23% decline from 2022.
- CorMedix Inc. annual Earnings Per Share, Diluted for 2022 was -0.74 USD/shares, a 1.33% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)